Laboratoire de Biophotonique et Pharmacologie
UMR CNRS 7213


Partenaires

CNRS
Logo Universite de strasbourg
 

Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Equipe Pharmacologie expérimentale et thérapeutique > Publications

Publication 2009

16 février 2012

M. ACHOUR, G. FUHRMANN, M. ALHOSIN, P. RONDE, T. CHATAIGNEAU, M. MOUSLI, V.B. SCHINI-KERTH & C. BRONNER. UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem. Biophys. Res. Commun. 390, 523-528, 2009 – IF 2.72

E. ANSELM, S.V. FROTA MADEIRA, S. DAL-ROS, C. SCHOTT, C. BRONNER & V.B. SCHINI-KERTH. Crataegus special extract WS 1442 causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of endothelial NO synthase but not via activation of estrogen receptors. J. Cardiovasc. Pharmacol. 53, 253-260, 2009 – IF 2.37

C. AUGER, T. CHATAIGNEAU & V. SCHINI-KERTH. Vascular protection by grape-derived polyphenols. Agro Food Ind. Hi-Tech 20, 38-40, 2009 – IF 0.17

C. BRONNER, G. FUHRMANN, F.L. CHEDIN, M. MACALUSO & S. DHE-PAGANON. UHRF1 links the histone code and DNA methylation to ensure faithful epigenetic memory inheritance. Genet. Epigenet. 2, 29-36, 2009 – IF n.a.

S. DAL-ROS, C. BRONNER, C. SCHOTT, M.O. KANE, M. CHATAIGNEAU, V.B. SCHINI-KERTH & T. CHATAIGNEAU. Angiotensin II-induced hypertension is associated with a selective inhibition of EDHF-mediated responses in the rat mesenteric artery. J. Pharmacol. Exp. Ther. 328, 478-486, 2009 – IF 4.09

Z. FANG, F. XING, C. BRONNER, Z. TENG & Z. GUO. ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells. Cell. Immunol. 257, 80-87, 2009 – IF 2.33

C. FEAU, E. KLEIN, C. DOSCHE, P. KERTH & L. LEBEAU. Synthesis and characterization of coumarin-based europium complexes and luminescence measurements in aqueous media. Org. Biomol. Chem. 7, 5259-5270, 2009 – IF 3.32

S.H. IHM, J.O. LEE, S.J. KIM, K.B. SEUNG, V.B. SCHINI-KERTH, K. CHANG & M.H. OAK. Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 206, 47-53, 2009 – IF 4.15

M.O. KANE, E. ANSELM, Y.D. RATTMANN, C. AUGER & V.B. SCHINI-KERTH. Role of gender and estrogen receptors in the rat aorta endothelium-dependent relaxation to red wine polyphenols. Vasc. Pharmacol. 51, 140-146, 2009 – IF 2.46

I. LAHMAR, A. ABOU-BACAR, T. ABDELRAHMAN, M. GUINARD, H. BABBA, S. BEN YAHIA, M. KAIRALLAH, C. SPEEG-SCHATZ, T. BOURCIER, A. SAUER, O. VILLARD, A.W. PFAFF, M. MOUSLI, J.G. GARWEG & E. CANDOLFI. Cytokine profiles in toxoplasmic and viral uveitis. J. Infect. Dis. 199, 1239-1249, 2009 – IF 6.10

S.V. MADEIRA, C. AUGER, E. ANSELM, M. CHATAIGNEAU, T. CHATAIGNEAU, R. SOARES DE MOURA & V.B. SCHINI-KERTH. eNOS activation induced by a polyphenol-rich grape skin extract in porcine cornary arteries. J. Vasc. Res. 46, 406-416, 2009 – IF 2.50

S. MARTIN, E.C. COSSET, J. TERRAND, A. MAGLOTT, K. TAKEDA & M. DONTENWILL. Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha5beta1 integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha5beta1 integrin antagonist. Biochim. Biophys. Acta-Mol. Cell Res. 1793, 354-367, 2009 – IF 5.02

A. SENEGAS, O. VILLARD, A. NEUVILLE, L. MARCELLIN, A.W. PFAFF, T. STEINMETZ, M. MOUSLI, J.P. KLEIN & E. CANDOLFI. Toxoplasma gondii-induced foetal resorption in mice involves interferon-gamma-induced apoptosis and spiral artery dilation at the maternofoetal interface. Int. J. Parasitol. 39, 481-487, 2009 – IF 3.94

N. SENNOUN, C. BARON-MENGUY, M. BURBAN, T. LECOMPTE, R. ANDRIANTSITOHAINA, D. HENRION, A. MERCAT, P. ASFAR, B. LEVY & F. MEZIANI. Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction : functional blood free activity on isolated mice arteries. Am. J. Physiol.-Heart Circul. Physiol. 297, H277-H282, 2009 – IF 3.86

J. TERRAND, V. BRUBAN, L. ZHOU, W. GONG, Z. EL ASMAR, P. MAY, K. ZURHOVE, P. HAFNER, C. PHILIPPE, E. WOLDT, R.L. MATZ, C. GRACIA, D. METZGER, J. AUWERX, J. HERZ & P. BOUCHER. LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J. Biol. Chem. 284, 381-388, 2009 – IF 5.50

M. UNOKI, J. BRUNET & M. MOUSLI. Drug discovery targeting epigenetic codes : the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem. Pharmacol. 78, 1279-1288, 2009 – IF 4.56

C. VALANT, E. MAILLET, J.J. BOURGUIGNON, B. BUCHER, V. UTARD, J.L. GALZI & M. HIBERT. Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor : structural exploration. J. Med. Chem. 52, 5999-6011, 2009 – IF 5.18

A. WALTER, N. ETIENNE-SELLOUM, D. BRASSE, R. SCHLEIFFER, V. BEKAERT, P.M. VANHOUTTE, A. BERETZ & V.B. SCHINI-KERTH. Red wine polyphenols prevent acceleration of neovascularization by angiotensin II in the ischemic rat hindlimb. J. Pharmacol. Exp. Ther. 329, 699-707, 2009 – IF 4.09

M. ZERR-FOUINEAU, M. JOURDAIN, C. BOESCH, M. HECKER, C. BRONNER & V.B. SCHINI-KERTH. Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 586-593, 2009 – IF 7.54

L. ZHOU, Y. TAKAYAMA, P. BOUCHER, M. TALLQUIST & J. HERZ. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS One 4, e6922, 2009 – IF 4.61